Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | AZD5851 |
Synonyms | |
Therapy Description |
Limited information is currently available on AZD5851, a putative chimeric antigen receptor (CAR) T-cell therapy targeting GPC3 (Oct 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AZD5851 | AZD-5851|AZD 5851 | Limited information is currently available on AZD5851, a putative chimeric antigen receptor (CAR) T-cell therapy targeting GPC3 (Oct 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06084884 | Phase Ib/II | AZD5851 | A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma (ATHENA) | Recruiting | USA | 1 |